Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.130
+0.010 (0.47%)
May 30, 2025, 4:00 PM - Market closed
Stereotaxis Revenue
Stereotaxis had revenue of $7.47M in the quarter ending March 31, 2025, with 8.60% growth. This brings the company's revenue in the last twelve months to $27.51M, up 1.50% year-over-year. In the year 2024, Stereotaxis had annual revenue of $26.92M with 0.55% growth.
Revenue (ttm)
$27.51M
Revenue Growth
+1.50%
P/S Ratio
6.68
Revenue / Employee
$197,914
Employees
139
Market Cap
183.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
STXS News
- 20 days ago - Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Stereotaxis Reports 2025 First Quarter Financial Results - GlobeNewsWire
- 5 weeks ago - Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 5 weeks ago - Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 - GlobeNewsWire
- 2 months ago - Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn - Seeking Alpha
- 3 months ago - Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript - Seeking Alpha